Anti-SMIM7/ C19orf42 functional antibody

Anti-SMIM7/ C19orf42 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SMIM7/SMIM7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0477-Ab-1/ GM-Tg-hg-SE0477-Ab-2Anti-Human SMIM7 monoclonal antibodyHuman
GM-Tg-rg-SE0477-Ab-1/ GM-Tg-rg-SE0477-Ab-2Anti-Rat SMIM7 monoclonal antibodyRat
GM-Tg-mg-SE0477-Ab-1/ GM-Tg-mg-SE0477-Ab-2Anti-Mouse SMIM7 monoclonal antibodyMouse
GM-Tg-cynog-SE0477-Ab-1/ GM-Tg-cynog-SE0477-Ab-2Anti-Cynomolgus/ Rhesus macaque SMIM7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0477-Ab-1/ GM-Tg-felg-SE0477-Ab-2Anti-Feline SMIM7 monoclonal antibodyFeline
GM-Tg-cang-SE0477-Ab-1/ GM-Tg-cang-SE0477-Ab-2Anti-Canine SMIM7 monoclonal antibodyCanine
GM-Tg-bovg-SE0477-Ab-1/ GM-Tg-bovg-SE0477-Ab-2Anti-Bovine SMIM7 monoclonal antibodyBovine
GM-Tg-equg-SE0477-Ab-1/ GM-Tg-equg-SE0477-Ab-2Anti-Equine SMIM7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0477-Ab-1/ GM-Tg-hg-SE0477-Ab-2; GM-Tg-rg-SE0477-Ab-1/ GM-Tg-rg-SE0477-Ab-2;
GM-Tg-mg-SE0477-Ab-1/ GM-Tg-mg-SE0477-Ab-2; GM-Tg-cynog-SE0477-Ab-1/ GM-Tg-cynog-SE0477-Ab-2;
GM-Tg-felg-SE0477-Ab-1/ GM-Tg-felg-SE0477-Ab-2; GM-Tg-cang-SE0477-Ab-1/ GM-Tg-cang-SE0477-Ab-2;
GM-Tg-bovg-SE0477-Ab-1/ GM-Tg-bovg-SE0477-Ab-2; GM-Tg-equg-SE0477-Ab-1/ GM-Tg-equg-SE0477-Ab-2
Products NameAnti-SMIM7 monoclonal antibody
Formatmab
Target NameSMIM7
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SMIM7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0477-Ag-1Recombinant multi-species SMIM7/ C19orf42 protein
    ORF Viral VectorvGMLP001249human SMIM7 Lentivirus particle
    ORF Viral VectorpGMLP001249human SMIM7 Lentivirus plasmid
    ORF Viral VectorpGMLPm002355mouse Smim7 Lentivirus plasmid
    ORF Viral VectorvGMLPm002355mouse Smim7 Lentivirus particle


    Target information

    Target IDGM-SE0477
    Target NameSMIM7
    Gene ID79086,66818,688495,106994662,610216,101094828,613429,100069519
    Gene Symbol and Synonyms9130011J15Rik,C19orf42,C20H19orf42,C7H19orf42,SMIM7
    Uniprot AccessionQ9BQ49,B0BN70,Q3SZ97
    Uniprot Entry NameSMIM7_HUMAN,SMIM7_RAT,SMIM7_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000214046
    Target ClassificationN/A

    The target: SMIM7, gene name: SMIM7, also named as C19orf42. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.